US OptionsDetailed Quotes
RIGL241220P28000
- 2.00
- 0.000.00%
15min DelayClose Dec 3 15:59 ET
0.00High0.00Low
2.00Open2.00Pre Close0 Volume1 Open Interest28.00Strike Price0.00Turnover91.08%IV3.88%PremiumDec 20, 2024Expiry Date0.95Intrinsic Value100Multiplier17DDays to Expiry1.05Extrinsic Value100Contract SizeAmericanOptions Type-0.5277Delta0.0753Gamma10.30Leverage Ratio-0.0615Theta-0.0071Rho-5.44Eff Leverage0.0232Vega
Rigel Pharmaceuticals Stock Discussion
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
25.+
Go, Go, Go!!!
No comment yet